Key Investor Signals
Four NooQ supplements on sale across three markets
AND Biotech sells four NooQ supplements through its own online store, with delivery to Switzerland, Germany and Austria. The current range is priced from CHF 44.90 to CHF 144.00.
SC Bern study found lower creatine kinase after 36 hours
A randomized, double-blind crossover study in professional SC Bern ice-hockey players found significantly lower creatine kinase 36 hours after Muscle Charge versus placebo.
CEO led Syngenta Seedcare across Europe, Africa and the Middle East
Marc-Olivier Zwicky spent 16 years at Syngenta, ending as Seedcare Head for Europe, Africa and the Middle East before co-founding AND Biotech.
Other Positive Signals
- Verified member listing with the Swiss Biotech Association, the national industry body.
- Advisory board includes J.P. de Magalhaes, professor of molecular biogerontology at the University of Birmingham.
- Advisers include the chief executive of Novochizol SA, a Swiss nanosphere drug-delivery company.
Team
Marc-Olivier Zwicky
CEO and Co-founder
- Spent 16 years at Syngenta, ending as Head of Seedcare for Europe, Africa and the Middle East from 2019 to 2024.
- Ran global sales for Syngenta Seedcare key accounts and previously led corn seed portfolio and supply-chain operations in Brazil.
- Has mentored early-stage founders at Startup Academy Switzerland since 2019 and served on Sigrun Agriculture's board in 2024 and 2025.
Nicolas Voëlin
CFO, COO and Co-founder
- Spent almost three years at Credit Suisse in global real estate asset management, covering acquisitions, modelling and product development.
- As Director of Investments at Club Estate, launched and managed a Luxembourg investment platform with more than €100M in volume.
- Has been managing director of Zum Kleinen Kirschgarten since 2021 and a strategist at Macro Real Estate since 2022.
Timm Klose
Co-founder, Sales and Marketing
- Played 17 times for Switzerland's senior national team and represented the country at the 2012 Olympic Games.
- Made more than 100 appearances for Norwich City and won the 2018/19 EFL Championship after Bundesliga spells in Germany.
- Has co-owned Basel members' business club Club de Bâle since 2014, alongside his professional football career.
Product
NooQ Nutrition is AND Biotech's commercial product line, with four supplements built around dietary nucleotides and established nutrients. The range is sold directly to consumers and targets daily vitality, muscle recovery, immune support and gut health.
Dietary nucleotides as a core input
The formulations use dietary nucleotides, the building blocks of DNA and RNA. Cell Vitality provides 340 mg per daily serving, Immune Shield 300 mg, and Muscle Charge 1.3 g.
Four formulas for distinct needs
Cell Vitality targets daily vitality, Muscle Charge muscle recovery, Immune Shield immune support and Gut Health digestive health. All four are sold directly through the NooQ store.
Nucleotides paired with established nutrients
Muscle Charge combines nucleotides with 3 g creatine, 10 g D-ribose and magnesium per daily sachet. Other formulas pair nucleotides with vitamins, minerals and additional bioactive ingredients.
Market Overview
Population aging expands the audience seeking to preserve physical and mental capacity over longer lives. WHO projects 2.1 billion people will be aged 60 or older by 2050 and notes that aging reflects accumulating cellular damage that gradually reduces physical and mental capacity.
Healthy eating, nutrition and weight loss was estimated by the Global Wellness Institute at $1.148 trillion globally in 2024. Established performance-nutrition brands also continue to grow, supporting a commercially validated consumer category alongside AND Biotech's earlier-stage medical R&D.
WHO projects the global population aged 60 and over to reach 2.1 billion by 2050.
AESGP/EPPA found 55% of 6,000 surveyed European consumers purchase food supplements.
Companies representing 65% of the EEA market expect about 5% sales growth over the next five years.
Glanbia reported 6.4% like-for-like revenue growth for Optimum Nutrition in 2025.
Comparable Outcomes
Thorne HealthTech
Thorne combined science-led supplements with at-home testing and personalized health recommendations, selling directly to consumers and through practitioners. Thorne completed its IPO in September 2021; L Catterton agreed to acquire the company in 2023 for approximately $680M.
The Bountiful Company
The Bountiful Company built vitamin and supplement brands including Nature's Bounty, Solgar, Osteo Bi-Flex and Puritan's Pride across retail, e-commerce and direct-to-consumer channels. Nestlé completed its $5.75B acquisition of the company's core brands in August 2021, adding them to Nestlé Health Science.
Interested in More Startups Like AND Biotech?
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.
Sources
This profile was built from public company materials, ecosystem sources, market references, and professional profiles.